[Improvement of venous diameter in bypass surgery: initial applications of ultraflexible biocompound grafts in patients].

Swiss surgery. Supplement Pub Date : 1996-01-01
H R Zurbrügg, H Zirngibl
{"title":"[Improvement of venous diameter in bypass surgery: initial applications of ultraflexible biocompound grafts in patients].","authors":"H R Zurbrügg,&nbsp;H Zirngibl","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The use of varicose-ectatically altered veins in bypass surgery is unsatisfactory due to unfavorable flow dynamics and high closure rates. To date surgical repair possibilities to improve the flow profile of autologous vein bypasses have been limited. Using the patient's own veins to produce a biocompound graft, i.e. an ultraflexible hybrid prosthesis, is a simple method by which the surgeon can influence the profile and wall pressure of the bypass. The authors hope thus to improve the patency rate. When forming a biocompound graft, a vein is intraoperatively sheathed inside a fine ultraflexible metal mesh and the two joined with fibrin glue. The mesh hose is pulled over the entire length of the vein with the aid of an application set. Biocompound grafts were used as aorto-coronary bypasses in 9 patients (5 women, 4 men) in whom the possibility of using alternative bypasses did not exist. In 2 patients with femoro-popliteal bypass procedure the autologous varicose-ectatically altered vein was used as a biocompound-graft. Aorto-coronary bypasses: at the time of discharge from the hospital all biocompound bypasses were patent. No perioperative myocardial infarctions were observed. No wound infections occurred. Femoro-popliteal bypasses: at time of discharge from the hospital all biocompound bypasses were patent. The results prove the simplicity and reliability of this method in difficult surgical cases. The biocompound graft offers the surgeon the possibility of using varicose-ectatic veins if alternative bypasses are not available.</p>","PeriodicalId":79460,"journal":{"name":"Swiss surgery. Supplement","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"1996-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Swiss surgery. Supplement","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The use of varicose-ectatically altered veins in bypass surgery is unsatisfactory due to unfavorable flow dynamics and high closure rates. To date surgical repair possibilities to improve the flow profile of autologous vein bypasses have been limited. Using the patient's own veins to produce a biocompound graft, i.e. an ultraflexible hybrid prosthesis, is a simple method by which the surgeon can influence the profile and wall pressure of the bypass. The authors hope thus to improve the patency rate. When forming a biocompound graft, a vein is intraoperatively sheathed inside a fine ultraflexible metal mesh and the two joined with fibrin glue. The mesh hose is pulled over the entire length of the vein with the aid of an application set. Biocompound grafts were used as aorto-coronary bypasses in 9 patients (5 women, 4 men) in whom the possibility of using alternative bypasses did not exist. In 2 patients with femoro-popliteal bypass procedure the autologous varicose-ectatically altered vein was used as a biocompound-graft. Aorto-coronary bypasses: at the time of discharge from the hospital all biocompound bypasses were patent. No perioperative myocardial infarctions were observed. No wound infections occurred. Femoro-popliteal bypasses: at time of discharge from the hospital all biocompound bypasses were patent. The results prove the simplicity and reliability of this method in difficult surgical cases. The biocompound graft offers the surgeon the possibility of using varicose-ectatic veins if alternative bypasses are not available.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[旁路手术中静脉直径的改善:超柔性生物复合移植物在患者中的初步应用]。
由于不利的血流动力学和高闭合率,在搭桥手术中使用曲张改变的静脉是不令人满意的。迄今为止,外科修复改善自体静脉旁路血流轮廓的可能性有限。利用患者自己的静脉制造生物复合移植物,即超柔性混合假体,是一种简单的方法,外科医生可以通过这种方法影响旁路的轮廓和壁压。作者希望以此来提高手术的通畅率。当形成生物复合移植物时,术中将静脉包裹在一个精细的超柔性金属网中,并用纤维蛋白胶将两者连接起来。在应用装置的帮助下,将网状软管拉过整个静脉长度。9例患者(5名女性,4名男性)采用生物化合物移植物作为主动脉-冠状动脉旁路,其中不存在使用其他旁路的可能性。在2例行股腘静脉搭桥手术的患者中,采用自体曲张改变静脉作为生物复合移植物。主动脉-冠状动脉旁路:出院时所有的生物化合物旁路都是专利的。围手术期未见心肌梗死。无伤口感染发生。股-腘动脉旁路:出院时所有的生物化合物旁路都是通畅的。结果表明,该方法简便、可靠,适用于外科疑难病例。如果没有其他的旁路手术,生物复合移植物为外科医生提供了使用曲张扩张静脉的可能性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Cannulated Screw Fixation of Femoral Neck Fractures in Elderly Patients [Small-caliber polyurethane arterial prosthesis: clinical and angiomorphological follow-up of 20 patients in a prospective study]. [Should heart surgery and thromboendarterectomy of the carotid artery be done simultaneously?]. [Asymptomatic endocarditis? Are consequent histological studies useful in valve surgery?]. [Analysis of early and late results of surgically treated Wolff-Parkinson-White syndrome].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1